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Among other genes, expression of the Bcl-6 transcriptional repressor distinguishes follicular helper T (Tfh)
cells from other helper T cell subsets. In this issue of Immunity, Yu et al. (2009) demonstrate that Bcl-6 directs
Tfh cell differentiation.The immune system of higher vertebrates
has a remarkable ability to identify the
particular order or even class of invading
microorganisms and tailor its response
accordingly. Distinct subsets of helper T
(Th) cells are induced by different patho-
gens, characterized by unique sets of
effector function and migration pattern.
The phenotype of each Th cell subset is
the result of distinctive gene expression
profiles, established by selective expres-
sion of master regulators (Zhou et al.,
2009). Since their original description by
Mosmann and Coffman, Th1 and Th2
cell subsets have been shown to differen-
tiate under the control of the transcription
factors T-bet and GATA-3, respectively
(Zhou et al., 2009). In more recent years,
regulatory T (Treg) cells and Th17 cells
have been recognized as separate sub-
sets, whose development is controlled
by the transcription factors FoxP3 and
RORgt, respectively (Zhou et al., 2009).
Follicular helper T (Tfh) cells are another
distinguishable subset of Th cells, spe-
cialized in providing help for B cell re-
sponses. After priming by antigen-pre-
senting dendritic cells (DCs) in the T cell
zone of secondary lymphoid organs, a
fraction of effector Th cells migrate to-
ward the B cell follicle, where they interact
with antigen-presenting B cells. Migration
of Tfh cells into the B cell follicle is gov-
erned to a large extent by regulated
chemokine receptor expression, namely
upregulation of CXCR5 and CXCR4 and
downregulation of CCR7 (Fazilleau et al.,
2009a). In addition to antigen presented
by B cells and recognized by the T cell
receptor (TCR), productive interaction
between Tfh cells and B cells is mediated
by an array of accessory molecules,
including CD40L, OX40, and ICOS on
Tfh cells and CD40, OX40L, and ICOSL
on B cells (Fazilleau et al., 2009a). This
interaction is required for subsequent450 Immunity 31, September 18, 2009 ª200generation of both plasma cells and
germinal center (GC) B cells, which is
tightly controlled by the cytokine secre-
tion profile of Tfh cells. Although Tfh cells
display a unique differentiation program,
nomaster transcription factor responsible
for initiating and maintaining this program
had been identified. Yu et al. (2009) in this
issue of Immunity and two other studies
published in Science (Johnston et al.,
2009; Nurieva et al., 2009) demonstrate
that the Tfh cell differentiation program
is controlled by B cell lymphoma 6 (Bcl-6).
Bcl-6 is a transcriptional repressor, and
its absence leads to defective GC forma-
tion and induction of T cell-dependent
antibody responses, in addition to an
ultimately fatal inflammatory syndrome.
Among Th cell subsets, Tfh cells display
selective expression of Bcl-6, which was
suggestive of a potential involvement of
Bcl-6 in Tfh cell generation. However,
cell-intrinsic control of GC B cell differen-
tiation by Bcl-6 had masked, until now,
the role for Bcl-6 in Tfh cell differentiation.
With different but complementary ap-
proaches to address the role of Bcl-6
specifically in T cells, the three new
studies clearly demonstrate that T cell-
specific deficiency in Bcl-6 prevents the
generation of Tfh cells and subsequently
the formation of GC and production of
antibodies (Johnston et al., 2009; Nurieva
et al., 2009; Yu et al., 2009). Th cells lack-
ing Bcl-6 failed to express Tfh cell-related
markers upon activation in vitro or in vivo.
In contrast, differentiation of Th1, Th2,
and Th17 cell subsets was enhanced in
the absence of Bcl-6. Of interest, Bcl-6
deficiency also reduced the generation
of FoxP3+ Treg cells in response to TGF-b
signaling, and this reduction was partly
due to enhanced Th1 and Th2 cell dif-
ferentiation of Bcl-6-deficient Th cells
(Nurieva et al., 2009). The new studies
also demonstrate that constitutive over-9 Elsevier Inc.expression of Bcl-6 in Th cell precursors
was sufficient to induce expression of
Tfh cell-related genes, including those
that encode CXCR5, CXCR4, PD-1, and
ICOS (Figure 1). At the same time, Bcl-6
overexpression directly inhibited the dif-
ferentiation of Th1, Th2, and Th17 cell
subsets.
The mechanism underlying inhibition of
Th1, Th2, and Th17 cell differentiation by
Bcl-6 involves its transcriptional repressor
activity. Indeed, similar to the reported
repression of the Th2 cell regulator
GATA-3 (Kusam et al., 2003), Bcl-6 was
found to bind directly to the promoters
of the human TBX21 and RORC genes,
encoding T-bet and RORgt, respectively,
suggesting that Bcl-6 may repress their
transcription (Yu et al., 2009). However,
direct transcriptional repression by Bcl-6
overexpression could be demonstrated
only for Tbx21 and Gata3 (Yu et al.,
2009), whereas Bcl-6 overexpression in-
hibited the activity, but not the expres-
sion, of RORgt (Nurieva et al., 2009).
Nevertheless, the DNA-binding activity
of Bcl-6 was critical for repression of
either expression or activity of all three
Th1, Th2, and Th17 cell master transcrip-
tion factors (Nurieva et al., 2009).
The transcriptional repressor activity of
Bcl-6 is seemingly difficult to connect
mechanistically with induction of Tfh
cell-specific genes. It could be that the
Tfh differentiation program is the default
pathway for activated Th cell precursors
when all other alternative pathways are
blocked by the action of Bcl-6. However,
Yu et al. (2009) further show that Bcl-6
also repressed expression of several
clusters of small single-stranded RNAs,
collectively known as microRNAs
(miRNAs), which are involved in posttran-
scriptional repression of target mRNAs.
Specificity of miRNA-mediated repres-
sion is provided by complementarity
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PreviewsFigure 1. Bcl-6 Drives Tfh Differentiation
Tfh cells represent a subset of Th cells, distinguishable from Th1, Th2, Treg, and Th17 cell subsets. Bcl-6
expression induces the Tfh cell differentiation program in Th cell precursors. Bcl-6 overexpression can
also divert Th cells at the early stages of commitment to other Th cell subsets into the Tfh cell lineage,
and may even convert fully differentiated Th1, Th2, Th17, or Treg cells into Tfh cells. Bcl-6 expression
is induced by IL-6 and the autocrine action of IL-21 and is suppressed by Blimp-1. In turn, Bcl-6 represses
Blimp-1, expression or activity of Th1 cell regulator T-bet, Th2 cell regulator GATA3, and Th17 cell regu-
lator RORgt. The balance of these transcription factors determines the composite helper effect of the T cell
on B cells. Bcl-6 additionally represses clusters of miRNAs, which negatively regulate CXCR5, CXCR4,
PD-1, and ICOS. Expression of the latter accessory molecules is thus indirectly induced. Bcl-6 also
induces expression of BTLA, CD200, and the receptors for IL-6 and IL-21; however, the precise mecha-
nism of this induction is currently unclear.between the miRNA and parts of the
target mRNA and several miRNAs can
target the same mRNA. Interestingly,
clusters of miRNAs repressed by Bcl-6
included those that target the mRNA en-
coding CXCR5, CXCR4, or PD-1 for
degradation (Yu et al., 2009). Further-
more, Bcl-6 represses two miRNAs,
which have been previously implicated in
repression of ICOS (Yu et al., 2007).
Although Yu et al. did not report upregula-
tion of ICOS in Bcl-6-overexpressing Tfh
cells, Bcl-6 overexpression did result in
elevated ICOS expression in Tfh cells re-
sponding in vivo to a viral infection (John-
ston et al., 2009). Therefore, several Tfh-
related genes may be indirectly induced
by Bcl-6, via release from miRNA-medi-
ated repression (Figure 1).
Although Bcl-6 repressed the key cyto-
kines associated with Th1, Th2, or Th17
cell differentiation, it did not affect the
production of IL-2 and IL-21. Both of
these cytokines are shared by other Th
cell subsets as well, and they can pro-
mote the growth of both T and B cells.
Despite strong repression of IFN-g, IL-17,
and IL-4 production by Bcl-6, Tfh cells
may still produce low amounts of these
cytokines. A substantial fraction of Tfh
cells generated in response to viral infec-
tion produced IFN-g (Johnston et al.,2009), and IL-4 production was found in
Tfh cells induced by parasitic infection
(Reinhardt et al., 2009). Importantly,
production of Th1 or Th2 cell cytokines
by Tfh cells appears to be vital for direct-
ing the appropriate switching of immuno-
globulin class (Reinhardt et al., 2009).
Furthermore, the overlap in cytokine pro-
duction may reflect shared or sequential
steps in the differentiation pathways of
Tfh and other Th cell subsets. Indeed,
Bcl-6 overexpression in Th cells that had
begun their Th1 or Th17 cell polarization
diverted them into the Tfh cell lineage
(Yu et al., 2009). It is possible that all Tfh
cells start life as another Th cell subset
(Figure 1). One important question that
arises is whether or not, once assumed,
the Tfh cell differentiation profile is stable.
Moreover, if the Tfh state of differentiation
is stable, the fate of Tfh cells after resolu-
tion of the immune response or during
chronic infection will be an important
element to determine.
Given the vital role for Bcl-6 in driving
the Tfh differentiation program, another
question that arises is what induces Bcl-6
expression in activated Th cell precur-
sors. Previous and current work by Nur-
ieva et al. (2008, 2009) has revealed that
Bcl-6 is induced by IL-6 and IL-21, but in-
hibited by TGF-b. The action of Bcl-6 wasImmunity 31,also antagonized by Blimp-1, and expres-
sion of Blimp-1 was repressed by Bcl-6
(Johnston et al., 2009), analogous with
the interplay of Bcl-6 and Blimp-1 in GC
B cells. Tfh cell differentiation, and by
extension Bcl-6 expression, was also
influenced by interaction of ICOS-ex-
pressing Th cells with ICOSL-positive B
cells (Nurieva et al., 2008), and ICOS over-
expression alone is sufficient to drive
excessive Tfh cell differentiation (Yu
et al., 2007). Moreover, Johnston et al.
(2009) reported a near-complete absence
of Tfh cells in mice lacking antigen-
specific B cells and antibodies. Similarly,
B cells have been shown to play a vital
role in the acquisition of the Tfh cell
phenotype, but not the loss of FoxP3
expression, during conversion of com-
mitted Treg cells into Tfh cells in gut
Peyer’s patches (Tsuji et al., 2009).
However, Th cell accumulation into the B
cell follicle is thought to be independent
of cognate interaction with B cells. Fur-
thermore, SAP deficiency in Th cells
prevents prolonged contact of Th cells
with follicular B cells and entry into the
GC, but does not prevent expression of
CXCR5 and ICOS or follicular localization
(Qi et al., 2008). These findings would
suggest that early Tfh cell differentiation
is initiated by antigen-presenting DCs
and that the full or permanent Tfh cell
profile is acquired after successful inter-
action with follicular and GC B cells.
Lastly, a recent report has associated
Tfh differentiation with higher-than-
average TCR affinity for antigen-MHC
class II complexes (Fazilleau et al.,
2009b), although the type of the antigen-
presenting cell that mediates this TCR
affinity selection process remains unclear.
Precisely how all these diverse signals are
integrated in Th precursors to induce Tfh
differentiation will require further investi-
gation.
Not only does the important finding that
Bcl-6 directs Tfh cell differentiation firmly
establish that Tfh cells are a separate
subset of Th cells, it also provides a better
means of identifying Tfh cells. Entry into
B cell follicles may not be an exclusive
privilege of Tfh cells, and not all Tfh cells
are found in B cell follicles. Furthermore,
thephenotypeofTfh cells is uniqueamong
Th cells only in the degree in which a
combination of markers are expressed.
This overlap in phenotype between
Th subsets has hindered accurateSeptember 18, 2009 ª2009 Elsevier Inc. 451
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Previewsidentification of Tfh cells. Just as the useof
FoxP3 has revolutionized the delineation
of Treg cells, the use of Bcl-6 as a molec-
ular marker will undoubtedly facilitate the
study of Tfh cells.
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strate that the IgE receptor Fc3RI in
For several decades, there has been a
passionate interest among immunologists
to understand the molecular mechanisms
bywhich immuno tyrosine activationmotif
(ITAM)-containing receptors such as Fc
receptor, T cell receptor (TCR), and B
cell receptor (BCR) transduce signals.
These signaling processes are of central
importance in understanding many
immune functions. In more recent years,
advances in imaging technologies have
revolutionalized our thinking about these
signaling processes. These live-imaging
techniques have revealed a very dynamic
picture of signaling. They have demon-
strated an importance of compartmen-
talization, membrane microdomains,
receptor diffusion and/or transport, the
role of cytoskeleton, receptor scaffolds,
and endocytosis as different dynamic
processes that regulate different stages
of signaling (Dustin, 2009). Studies on
the TCR and BCR have revealed the
formation of the immune synapse and mi-
croclusters as sites of signal initiation
(Dustin, 2009). These studies, consistent
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with previous work on IgE receptors,
have revealed a hierarchy of receptor
assemblies showing inverse correlation
between sizes of complex and signaling
(Seagrave et al., 1991). However, one
common insight that has emerged out of
these studies is that immobilization of
ligand-engaged receptors is strongly
correlated with the ability of these recep-
tors to signal (Varma, 2008). Therefore,
most models of signaling have relied on
kinetic parameters of receptor-ligand
interactions that facilitate receptor immo-
bilization. In this issue of Immunity, An-
drews et al. (2009) use single-molecule
fluorescence microscopy of quantum
dot (QD)-labeled receptors to demon-
strate that signaling occurs when recep-
tors are mobile.
Signaling via the high-affinity IgE recep-
tor Fc3RI is initiated when IgE-engaged Fc
receptors are crosslinked via antigen. In
the earliest steps of signaling, Fc3RIb and
Fc3RIg are phosphorylated by Lyn kinase.
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downstreamsignaling tocalciummobiliza-
tion and Ras and/or MAP-kinase pathway
activation, which leads to downstream
responses such as degranulation and cy-
tokine production. For over three decades,
the relationship between diffusion and
signaling for IgE receptors has been exten-
sively studied by numerous groups using
different biophysical approaches (Hol-
owka and Baird, 1996). Most groups
arrived at the conclusion that receptor
immobilization is correlated with initiation
of a degranulation response. However,
early studies showed that making sig-
naling-competent small signaling clusters
didnotcausemarked receptor immobiliza-
tion, but creating larger signaling com-
plexes that would inhibit signaling did
(Mendoza and Metzger, 1976; Schles-
singer et al., 1976). Studies by Menon
et al. (1986) arrived at the conclusion that
by making dimeric anti-IgE complexes,
there was poor degranulation associated
with a lack of receptor immobilization.
Hence, there was a need to address this
issuewith a sensitive technique that allows
